Working to Eradicate Gynecologic Cancers

Jennifer M. Scalici, MD

Assistant Professor
University of South Alabama-Mitchell Cancer Institute
1660 Springhill Ave
Mobile, AL
USA 36604


Biographical Sketch:
Henretta M, Scalici J, Engelhard C, Duska L. The revolving door: Hospital re-admissions of gynecologic oncology patients. Gynecologic Oncology. Sep; 122 (3): 479-83. June 12, 2011 Courtney-Brooks M, Tellawi AR, Scalici J, Duska LR, Jazaeri AA, Modesitt SC, Cantrell LA. Frailty: an outcome predictor for elderly gynecologic oncology patients. Gynecologic Oncology. Jul; 126 (1) 20-4. University of Virginia Health System: Gynecologic Oncology Fellowship 2012 including robotic training"

Papers:
151 Dietary isothiocyanates inhibit cancer cell growth by inducing replication stress mediated DNA damage response 276 Peritoneal vascular cell adhesion molecule 1 (VCAM-1) is a marker of response to therapy and overall survival in epithelial ovarian cancer (EOC) 430 Early detection of ovarian cancer via a self-sampling screening test of vaginal secretions: feasibility and patient acceptance 496 False positive identification of sentinel lymph nodes with robotic fluorescence imaging and ICG in endometrial and cervical cancer 520 Investigating the role of phosphodiesterase 10A as a novel target in ovarian cancer